

Cover Story
Real-world Evidence
Routine screening procedures for breast, colon, and cervical cancers in the first half of 2021 have failed to recover, falling by about a third below historical baselines, even as Americans are resuming normal activities.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- NCI braces for funding cuts, shutdown
- White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Most NIH activities will cease immediately if government shuts down
- AACR creates an alliance of academic cancer centers
Foti, Willman, Weiner, and Winn tell us what the new group will seek to accomplish - Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home